Nuclear receptors and human disease: resistance to thyroid hormone and lipodystrophic insulin resistance.
Chatterjee
V K K
VK
Metabolic Research Laboratories, Level 4, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom. kkc1@mole.bio.cam.ac.uk
D000818:Animals; D050171:Dyslipidemias / Q000378:metabolism*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D047495:PPAR gamma / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D018382:Thyroid Hormone Resistance Syndrome / Q000503:physiopathology; D013963:Thyroid Hormones / Q000502:physiology*
D047495:PPAR gamma; D018160:Receptors, Cytoplasmic and Nuclear; D013963:Thyroid Hormones